Alogliptin Release Delayed
Links shared publicly online about this topic
Alogliptin delayed at least two years
theheart.org — “The makers of alogliptin say it will be two years before they have the cardiovascular data needed by the FDA, while the EASD raises concerns over a possible cancer risk with insulin glargine.” View full resource at theheart.org
Most Recently Shared on June 30, 2009 at 8:05 pm By:
heartwire: Alogliptin delayed; cancer concerns with insulin glargine http://bit.ly/3SgOg4
Insufficient CV safety data for alogliptin, FDA says
theheart.org — “According to new guidance issued in December, the manufacturer will need to obtain more CV-safety data for the FDA, despite submitting its NDA back in 2007.” View full resource at theheart.org
Most Recently Shared on March 12, 2009 at 4:11 pm By:
"Insufficient" data: FDA applies tough new CV-safety requirements to diabetes drug alogliptin http://tinyurl.com/djbzot
Dr. Reddy's Announces The Approval Of Lansoprazole Delayed-Release Capsules
medicalnewstoday.com — “Dr. Reddy's Laboratories (NYSE: RDY) announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid® Delayed-Release C” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 5:05 pm By:
MNT Drug Approvals Health News
Dr. Reddy's Announces The Approval Of Lansoprazole Delayed-Release Capsules http://mnt.to/3Lrx #regulatory
Delayed-Release Form of Risedronate Approved - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A delayed-release formulation of the osteoporosis drug risedronate, which may be easier for some patients to take, has won FDA approval, its manufacturer announced.” View full resource at qualitypointtech.net
Most Recently Shared on October 11, 2010 at 9:37 pm By:
Delayed-Release Form of Risedronate Approved: (MedPage Today) -- A delayed-release formulation of the osteoporosis... http://bit.ly/9lnlYe
Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
empr.com — “Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a zero-overfill pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.” View full resource at empr.com
Most Recently Shared on July 7, 2009 at 9:48 pm By:
MPR News: Creon delayed-release capsules available for exocrine pancreatic insufficiency: Solvay Pharma.. http://tinyurl.com/mzjwfn
EPA Delays Release of Final Ozone Standards - NYTimes.com
nytimes.com — “U.S. EPA won't meet its goal of releasing new nationwide standards for ground-level ozone this month, the agency told a feder...” View full resource at nytimes.com
Most Recently Shared on August 24, 2010 at 3:56 am By:
NYTimes - EPA Delays Release of Final Ozone Standards http://bit.ly/ciZncA
Teva's Lansoprazole Delayed-Release Orally Disintegrating Tablets Withdrawn - ONA
oncologynurseadvisor.com — “Teva Pharmaceuticals has voluntarily withdrawn its lansoprazole delayed-release orally disintegrating tablets (ODT) product from distribution after the FDA received reports of clogged and blocked oral syringes and feeding tubes when the drug is administered as a suspension through these devices.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 15, 2011 at 4:17 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Teva's Lansoprazole Delayed-Release Orally Disintegrating Tablets Withdrawn http://goo.gl/fb/Ex9AQ
Teva's Lansoprazole Delayed-Release Orally Disintegrating Tablets Withdrawn - MPR
empr.com — “Teva Pharmaceuticals has voluntarily withdrawn its lansoprazole delayed-release orally disintegrating tablets (ODT) product from distribution after the FDA received reports of clogged and blocked oral syringes and feeding tubes when the drug is administered as a suspension through these devices.” View full resource at empr.com
Most Recently Shared on April 15, 2011 at 4:18 pm By:
MPR News: Teva's Lansoprazole Delayed-Release Orally Disintegrating Tablets Withdrawn: Teva Pharmaceuticals has ... http://bit.ly/i2Tgfu
Storm delays release of gas drilling report - Times Union
timesunion.com — “Faced with the devastation of Tropical Storm Irene, the state Department of Environmental Conservation is delaying the release of its long-anticipated report on the socio-economic impact of hydraulic fracturing, or hydrofracking. DEC spokesman Emily DeSantis said the remaining section of the draft generic environmental impact statement, which could have been released this week, will now be issued next week.” View full resource at timesunion.com
Most Recently Shared on September 1, 2011 at 12:04 pm By:
Don Carli - dcarli Green Advocate
Storm delays release of NY State DEC gas drilling report - Times Union http://t.co/7H5ee8L #fracking
New HIV prevention findings delay release of WHO guidelines for discordant couples
news-medical.net — “"Upbeat new HIV prevention findings presented last week at an international AIDS conference held in Rome have complicated attempts by the World Health Organization (WHO) to draft much-anticipated guidelines for heterosexual couples in which one partner is infected," ScienceInsider reports.” View full resource at news-medical.net
Most Recently Shared on July 27, 2011 at 10:37 am By:
HIV/AIDS News: New HIV prevention findings delay release of WHO guidelines for discordant couples: "Upbeat new H... http://bit.ly/pNhd51
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
medicalnewstoday.com — “Solvay Pharmaceuticals, Inc. announced that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exo” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2009 at 11:14 am By:
MNT Clinical Trials Health News
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatiti.. http://bit.ly/AjVpS
Teva Receives Final Approval For Generic Prevacid(R) Delayed-Release Capsules
medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) t” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2009 at 10:33 am By:
#HEALTH Teva Receives Final Approval For Generic Prevacid(R) Delayed-Release Capsules http://ow.ly/161aLd
New HIV Prevention Findings Delay Release of WHO Guidelines for Discordant Couples - The Body
thebody.com — “'Upbeat new HIV prevention findings presented last week at an international AIDS conference held in Rome have complicated attempts by the World Health ...” View full resource at thebody.com
Most Recently Shared on July 26, 2011 at 8:01 pm By:
New HIV Prevention Findings Delay Release of WHO Guidelines for Discordant Couples http://bit.ly/pqtjP8 #aids #prep #prevention
More Americans plan to delay retirement: surveys | Reuters
reuters.com — “BOSTON (Reuters) - More Americans plan to delay retirement following steep drops in the value of their savings accounts, data from several new surveys show. A study to be released on Thursday by Canadian” View full resource at reuters.com
Most Recently Shared on October 22, 2009 at 11:08 pm By:
Timothy Lomauro Doctor, Psychologist, and PhD
@daschles - "More Americans plan to delay retirement: surveys" http://hub.tm/?adxXO
Delay In Diagnosis Significantly Impacts Lives Of Patients With Fibromyalgia
medicalnewstoday.com — “Results released from a national survey of U.S. women with fibromyalgia, illustrate the private and prolonged physical and emotional struggles patients with this condition face, underscored by del” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2010 at 2:26 pm By:
Delay In Diagnosis Significantly Impacts Lives Of Patients With Fibromyalgia: Results released from a national s... http://mnt.to/f/3N38
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
